Brokerages Set Plexus Corp. (NASDAQ:PLXS) Price Target at $204.20

Plexus Corp. (NASDAQ:PLXS) has been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $229.1667.

A number of analysts recently issued reports on PLXS shares. Williams Trading set a $195.00 target price on shares of Plexus in a research report on Wednesday, January 28th. Weiss Ratings downgraded shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, April 24th. Zacks Research downgraded shares of Plexus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 13th. Stifel Nicolaus set a $250.00 price objective on shares of Plexus and gave the company a “buy” rating in a research report on Monday, April 20th. Finally, Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a research report on Saturday.

Insider Buying and Selling

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $224.09, for a total value of $336,135.00. Following the completion of the sale, the chief executive officer owned 80,291 shares of the company’s stock, valued at $17,992,410.19. This trade represents a 1.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Marie Rapp sold 500 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $195.59, for a total transaction of $97,795.00. Following the completion of the sale, the director directly owned 8,535 shares of the company’s stock, valued at $1,669,360.65. This trade represents a 5.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 50,995 shares of company stock valued at $10,345,971 over the last three months. Company insiders own 1.78% of the company’s stock.

Institutional Trading of Plexus

Several large investors have recently bought and sold shares of PLXS. Inspire Investing LLC grew its position in shares of Plexus by 1.6% during the fourth quarter. Inspire Investing LLC now owns 3,178 shares of the technology company’s stock worth $467,000 after buying an additional 50 shares in the last quarter. Allworth Financial LP grew its position in shares of Plexus by 20.8% during the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock worth $44,000 after buying an additional 52 shares in the last quarter. Maryland State Retirement & Pension System grew its position in shares of Plexus by 1.5% during the fourth quarter. Maryland State Retirement & Pension System now owns 3,940 shares of the technology company’s stock worth $579,000 after buying an additional 60 shares in the last quarter. Oregon Public Employees Retirement Fund grew its position in shares of Plexus by 1.2% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,175 shares of the technology company’s stock worth $908,000 after buying an additional 71 shares in the last quarter. Finally, Uncommon Cents Investing LLC grew its position in shares of Plexus by 0.8% during the fourth quarter. Uncommon Cents Investing LLC now owns 9,925 shares of the technology company’s stock worth $1,459,000 after buying an additional 75 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus News Roundup

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Q2 results and raised guidance — Plexus reported stronger-than-expected Q2 revenue (about $1.16B, roughly +18.7% Y/Y) and beat headline EPS consensus; management also issued fiscal Q3 guidance above Street estimates (EPS guidance of 2.020–2.180 and revenue guidance above prior consensus), supporting a higher-growth outlook. Earnings Press Release
• Positive Sentiment: Analyst upgrade / price-target lift — Needham raised its price target to $285 and reaffirmed a Buy, lending institutional support and providing a near-term catalyst for momentum and flows. Benzinga
• Positive Sentiment: Momentum and ETF interest — Coverage has highlighted Plexus as a momentum play and noted index/ETF buying buzz after the strong quarter, which can amplify upside through passive flows and quant strategies. Kalkine
• Neutral Sentiment: Analyst consensus / ratings landscape — The street consensus is around a “Moderate Buy” with varied price targets (median near $220); recent upgrades improve sentiment but coverage is limited, so future moves depend on continued execution. American Banking News
• Neutral Sentiment: Investor materials and call transcripts available — Management provided a slide deck and earnings call transcript that detail program wins and demand drivers; investors should review guidance detail and margin commentary for forward visibility. Earnings Presentation
• Negative Sentiment: CFO transition announced — CFO Patrick Jermain plans to retire; while Plexus says succession is disciplined, CFO turnover introduces near-term execution and disclosure risk that some investors view negatively. CFO Transition
• Negative Sentiment: Insider selling and cash-flow notes — Data shows notable insider sales in recent months and some operating cash conversion metrics were weaker y/y; these factors may temper enthusiasm and raise governance/cash-flow questions for value-focused investors. QuiverQuant

Plexus Stock Up 5.6%

PLXS opened at $264.60 on Friday. The firm has a 50 day moving average price of $211.79 and a 200 day moving average price of $178.77. The company has a market cap of $7.09 billion, a PE ratio of 38.68 and a beta of 0.88. Plexus has a 1 year low of $115.35 and a 1 year high of $272.08. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.54.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.18. The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.13 billion. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The company’s revenue was up 18.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.66 EPS. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Sell-side analysts expect that Plexus will post 6.56 earnings per share for the current year.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.